4//SEC Filing
Gerngross Tillman U. 4
Accession 0001209191-22-006022
CIK 0001832038other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 6:14 PM ET
Size
5.5 KB
Accession
0001209191-22-006022
Insider Transaction Report
Form 4
Gerngross Tillman U.
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-01-30+175,000→ 175,000 totalExercise: $6.78Exp: 2032-01-29→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four-year period measured from one month following January 30, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.
Documents
Issuer
Adagio Therapeutics, Inc.
CIK 0001832038
Entity typeother
Related Parties
1- filerCIK 0001722061
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 6:14 PM ET
- Size
- 5.5 KB